BioPharma Global in the Media

Clinical Network Services And BioPharma Global Enter Cooperative Partnership

Clinical Network Services (CNS), an international clinical and regulatory service group and BioPharma Global, an Orphan Drug regulatory consultancy, operating as a US-based, not-for-profit corporation, today announced they have signed a cooperative partnership agreement.

Click here to read on PRWeb

Our Chat with Health Professional Radio

Biopharma Global Board Chair Carolyn Thompson and CEO James LaFLamme recently sat down with Neal Howard at Health Professional Radio to discuss orphan drugs, the FDA/EMA approval process, and rare disease research.

Click here to listen

Indiana Wesleyan University’s Alumni Blog Profiles James LaFlamme

Our CEO, James LaFlamme, has been profiled by Dezaray Barr in the Indiana Wesleyan University Alumni Blog. James graduated from Indiana Wesleyan University in 1988 with a Masters in Management.

While a student at IWU, LaFlamme also held a full-time job as an executive. “I would describe this period of time as intense,” LaFlamme said, “but I met a lot of great people and the learning environment at IWU was outstanding.”

Click here to read the full post

James LaFlamme Introduces BioPharma Global

James LaFlamme introduced BioPharma Global in a new YouTube release answering the following questions.

Who is BioPharma Global, and what do we do?

How do we differentiate ourselves from our competitors?

And much more.